Back to all studies
Not Yet RecruitingNCT07390981

Selective Serotonin Reuptake Inhibitors (SSRIs) for depression

This study is not yet recruiting. It is testing Selective Serotonin Reuptake Inhibitors (SSRIs) for depression.

DepressionBehavioralFrom 18 Years to 60 Years

The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.

Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT07390981. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

Check the official registry

No specific site is confirmed in the available information. Check the official source for locations and remote participation.

In plain English

Key information made simple

What is this study testing?

This study is testing whether acupuncture may be useful for adults experiencing depression.

What would participation involve?

Participants may take part in acupuncture, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group.

Who is it mainly for?

This study appears to be mainly for adults with depression.

What should you check before joining?

Ask about how many sessions are required and who delivers them, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

Participation locations and format are not confirmed in the available information. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateEstimated: March 1, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
114
Sponsor
First People's Hospital of Hangzhou
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Medication / drug, PROCEDURE
Study phase
Not clearly listed
Locations
Not clearly listed
Age range
From 18 Years to 60 Years
Official registry ID
NCT07390981
Official title
Clinical Efficacy of Intradermal Acupuncture as an Adjunct to SSRI Dose Reduction or Discontinuation in Patients With Major Depressive Disorder and Its Mechanisms of Autonomic Nervous System Regulation
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT07390981. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Confirm the location and whether remote participation is possible with the research team.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring psychotherapy or therapy for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving Selective Serotonin Reuptake Inhibitors (SSRIs), Sham Intradermal Acupuncture, Intradermal Acupuncture. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 60 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Will I need to change, stop, or stabilize my current treatment?

The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by First People's Hospital of Hangzhou, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me